Boothbay Fund Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53K Hold
18,334
﹤0.01% 1923
2025
Q4
$29.5K Sell
18,334
-5,178
-22% -$8.14K ﹤0.01% 1860
2025
Q3
$39.5K Hold
23,512
﹤0.01% 1800
2025
Q2
$28.4K Hold
23,512
﹤0.01% 1383
2025
Q1
$29.9K Hold
23,512
﹤0.01% 1311
2024
Q4
$76.4K Sell
23,512
-8
-0% -$29 ﹤0.01% 1319
2024
Q3
$77.4K Sell
23,520
-35,243
-60% -$137K ﹤0.01% 1478
2024
Q2
$250K Sell
58,763
-38,940
-40% -$379K 0.01% 1219
2024
Q1
$1.44M Buy
+97,703
New +$1.48M 0.03% 625
2023
Q2
Sell
-50,175
Closed -$360K 2095
2023
Q1
$360K Buy
+50,175
New +$302K 0.01% 1419
2022
Q2
Sell
-15,663
Closed -$138K 2503
2022
Q1
$138K Sell
15,663
-1,857
-11% -$20.5K ﹤0.01% 2020
2021
Q4
$281K Sell
17,520
-7,775
-31% -$146K 0.01% 1299
2021
Q3
$530K Sell
25,295
-30,784
-55% -$742K 0.01% 1060
2021
Q2
$1.51M Sell
56,079
-4,364
-7% -$128K 0.05% 515
2021
Q1
$1.93M Buy
+60,443
New +$1.47M 0.07% 339
2020
Q2
Sell
-39,910
Closed -$232K 1057
2020
Q1
$232K Buy
+39,910
New +$362K 0.02% 634

Other funds holding MGNX

Boothbay Fund Management's MGNX Position: Q1 2026 in Review

Boothbay Fund Management held its MacroGenics (MGNX) position steady in Q1 2026 at 18,334 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Boothbay Fund Management first reported a position in MGNX in Q1 2020 and has held it in 16 quarters since. The position peaked at $1.93M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Boothbay Fund Management held 18,334 shares of MacroGenics worth $53K as of Q1 2026.
  • Boothbay Fund Management left its MacroGenics share count unchanged in Q1 2026.
  • MacroGenics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1923 holding.
  • Boothbay Fund Management first reported a position in MacroGenics in Q1 2020 and has held it in 16 quarters since.
  • Boothbay Fund Management's MacroGenics position peaked at $1.93M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.